SC
HAE icon

Schubert & Co’s Haemonetics HAE Stock Holding History

Schubert & Co’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-26
Closed -$2.15K – 662
2023
Q1 		$2.15K Sell
26
-2
-7% -$162 ﹤0.01% 882
2022
Q4 		$2.2K Sell
28
-2
-7% -$161 ﹤0.01% 819
2022
Q3 		$2K Buy
30
+9
+43% +$646 ﹤0.01% 807
2022
Q2 		$1K Buy
21
+12
+133% +$710 ﹤0.01% 1112
2022
Q1 		$1K Buy
9
+5
+125% +$272 ﹤0.01% 715
2021
Q4 		$0 Buy
+4
New +$244 ﹤0.01% 1116

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Schubert & Co's HAE Position: Q2 2023 in Review

Schubert & Co sold out of Haemonetics (HAE) in Q2 2023, closing a stake of 26 shares — an estimated $2.15K sold.

Schubert & Co first reported a position in HAE in Q4 2021 and held it in 6 quarters. The position peaked at $2.2K in Q4 2022. 294 funds tracked by Wall St. Rank hold HAE as of Q2 2023.

  • Schubert & Co reported no remaining Haemonetics position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 26 Haemonetics shares in Q2 2023, an estimated $2.15K.
  • Schubert & Co first reported a position in Haemonetics in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Haemonetics position peaked at $2.2K in Q4 2022.
  • 294 funds tracked by Wall St. Rank held Haemonetics as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.